|
000
| 02152cam 2200289za 4500 |
|---|
| 001 | 9.822963 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107143807 |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 160819s2008 onca |o f|0| 0 eng d |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH14-164/2008E-PDF |
|---|
| 245 | 00|aCanada's Access to Medicines Regime (CAMR) |h[electronic resource] : |bimplementation - focused evaluation of Health Canada's responsibilities; final report. |
|---|
| 260 | |a[Ottawa] : |bHealth Canada, |c2008. |
|---|
| 300 | |a[71] p. in various pagings : |bill., exhibits. |
|---|
| 500 | |aIssued also in French under title: Régime canadien d'accès aux médicaments (RCAM), Évaluation axée sur la mise en oeuvre, des responsabilités de Santé Canada; rapport final. |
|---|
| 500 | |a"April 28, 2008." |
|---|
| 500 | |a"Approved by Departmental Executive Committee on Finance, Evaluation and Accountability (DEC-FEA) Health Canada." |
|---|
| 504 | |aIncludes bibliographic references. |
|---|
| 520 | |aIn May 2007, Health Canada commenced an implementation-focused evaluation of its responsibilities under CAMR, the purpose of which is to provide senior management in Health Products and Food Branch (HPFB) with timely information on how well CAMR has been implemented. This will enable mid-course corrections to be taken, if required, increasing the likelihood of achieving expected outcomes that countries and manufacturers participate in the regime, and that products developed meet Canadian standards and regulatory requirements and are distinguishable from patented products. The requirement to conduct an evaluation arose from Health Canada’s Treasury Board (TB) Submission to access CAMR funds. The scope is on Health Canada’s activities associated with implementing CAMR during the period of FY 2004-05 to FY 2006-07. ... |
|---|
| 692 | 07|2gccst|aMedicine |
|---|
| 692 | 07|2gccst|aHealth |
|---|
| 692 | 07|2gccst|aProgram assessment |
|---|
| 710 | 1 |aCanada. |bHealth Canada. |
|---|
| 775 | 08|tRégime canadien d'accès aux médicaments (RCAM) |w(CaOODSP)9.822967 |
|---|
| 856 | 40|qPDF|s412 KB|uhttps://publications.gc.ca/collections/collection_2016/sc-hc/H14-164-2008-eng.pdf |
|---|